1,041 material Form 8-K filings that 824 companies we cover made with the SEC in November 2025, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
EPAM Systems reported third-quarter 2025 revenue of $1.394 billion, up 19.4% from a year earlier, while GAAP diluted EPS fell 19.4% to $1.91 and non-GAAP diluted EPS fell 1.3% to $3.08. The company raised its full-year 2025 revenue outlook to $5.430 billion to $5.445 billion and its full-year EPS outlook, and expects fourth-quarter revenue of $1.380 billion to $1.395 billion. Shareholders also received an update on capital returns, including $82.1 million of buybacks in the quarter and a new $1.0 billion repurchase program approved October 16, 2025.
Q3 2025 revenue of $1.394 billion, up 19.4% year over year; organic constant currency growth was 7.1%
Q3 GAAP diluted EPS of $1.91, down $0.46 or 19.4%; non-GAAP diluted EPS of $3.08, down $0.04 or 1.3%
Full-year 2025 revenue outlook raised to $5.430 billion to $5.445 billion; GAAP diluted EPS outlook $6.75 to $6.83, non-GAAP $11.36 to $11.44
Repurchased $82.1 million of stock in Q3; board approved a new repurchase program of up to $1.0 billion on October 16, 2025
Talos Energy reported a third-quarter 2025 net loss of $95.9 million, or $0.55 per diluted share, which includes a $60.2 million non-cash impairment, on total revenues of $450.1 million. The company also raised its full-year 2025 average daily production guidance to 94.0 to 97.0 MBoe/d and lowered its cash operating expense and capital expenditure ranges.
Q3 2025 net loss of $95.9 million ($0.55 per diluted share); adjusted net loss of $33.0 million ($0.19 per share)
Full-year 2025 production guidance raised to 94.0-97.0 MBoe/d from 91.0-95.0 MBoe/d
Full-year 2025 capital expenditure guidance lowered to $480-520 million from $490-530 million
Repurchased about 5.0 million shares for $48.1 million in Q3; $332.7 million cash at September 30, 2025
Kinetik reported third-quarter 2025 net income including noncontrolling interest of $15.5 million, down from $83.7 million a year earlier, while total operating revenues rose to $464.0 million from $396.4 million. The company now expects full-year 2025 Adjusted EBITDA of $965 million to $1.005 billion, citing slower Kings Landing ramp-up, producer delays, lower commodity prices, and the October EPIC Crude sale.
Q3 2025 diluted EPS attributable to Class A holders was $0.03, versus $0.35 in Q3 2024
Q3 Adjusted EBITDA was $242.6 million, versus $265.7 million a year earlier
2025 Adjusted EBITDA guidance revised to $965 million to $1.005 billion; 2025 capital guidance tightened to $485 million to $515 million
Closed sale of 27.5% EPIC Crude interest in October 2025 with over $500 million in net upfront cash
Ralliant reported third-quarter 2025 revenue of $529 million, flat year-over-year and up 5% sequentially, while net earnings were $40 million, down from $91 million a year earlier. The company issued fourth-quarter revenue guidance of $535 million to $550 million and adjusted EPS guidance of $0.62 to $0.68, and declared a $0.05 quarterly dividend.
Net earnings of $40 million, or $0.35 per diluted share, versus $91 million, or $0.81 per diluted share, a year earlier; adjusted EPS was $0.60.
Test & Measurement revenue fell 14% to $203 million and posted a $2 million operating loss; Sensors & Safety Systems revenue rose 11% to $326 million.
Fourth-quarter 2025 outlook: revenue of $535 million to $550 million and adjusted EPS of $0.62 to $0.68.
Board declared a $0.05 per share dividend on October 30, 2025, payable December 23, 2025; a $200 million share repurchase authorization was approved June 28, 2025.
Ellington Financial reported third-quarter 2025 results on November 5, 2025. GAAP net income attributable to common stockholders was $0.29 per share, down from $0.45 in the prior quarter, while Adjusted Distributable Earnings were $0.53 per share. Net interest income rose to $49.7 million from $43.3 million, and the company priced $400 million of five-year senior unsecured notes, which shifts more of its borrowing to longer-term financing.
Net income attributable to common stockholders was $29.5 million, or $0.29 per share, for the quarter ended September 30, 2025, compared with $42.9 million, or $0.45 per share, for the quarter ended June 30, 2025.
Adjusted Distributable Earnings were $54.2 million, or $0.53 per share, including $16.1 million, or $0.16 per share, from Longbridge.
Book value per common share was $13.40 as of September 30, 2025, including the effects of $0.39 per share in dividends for the quarter.
Recourse debt-to-equity ratio was 1.8:1 as of September 30, 2025; $400 million of senior unsecured notes priced at a 7.375% yield and closed after quarter end.
APA Corporation reported third-quarter 2025 results on November 5, 2025. Net income attributable to common stock was $205 million, or $0.57 per diluted share, compared with a loss of $223 million a year earlier, while adjusted earnings were $332 million, or $0.93 per share, down from $370 million, or $1.00. Total revenues fell to $2.1 billion from $2.5 billion, but the company raised its fourth-quarter U.S. oil production guidance and expects $350 million in run-rate cost savings by year-end 2025.
Total revenues were $2,115 million in the third quarter of 2025, versus $2,531 million in the same quarter of 2024.
Adjusted earnings were $332 million ($0.93 per diluted share), versus $370 million ($1.00 per share) a year earlier.
Net debt was reduced by approximately $430 million in the quarter to roughly $4.0 billion, and free cash flow was $339 million.
U.S. oil production guidance for the fourth quarter was raised to 123,000 barrels per day, and run-rate savings are expected to reach $350 million by year-end 2025.
Centrus Energy reported third quarter 2025 results with net income of $3.9 million, or $0.19 per diluted share, compared with a net loss of $5.0 million a year earlier. Revenue rose 30% to $74.9 million, but the company posted a gross loss of $4.3 million and an operating loss of $16.6 million, and the profit was supported by a $12.9 million investment income line and an $11.9 million income tax benefit.
Total revenue of $74.9 million, up from $57.7 million in Q3 2024; LEU segment revenue was $44.8 million and Technical Solutions revenue was $30.1 million
Gross loss of $4.3 million, compared with gross profit of $8.9 million in Q3 2024; LEU segment gross loss of $7.8 million
Cash and cash equivalents of $1,631.8 million at September 30, 2025, after the $805.0 million 0% convertible senior notes issued August 18, 2025
Backlog of $3.9 billion as of September 30, 2025, extending to 2040
Interparfums reported third-quarter 2025 net income attributable to the company of $66 million, or $2.05 per diluted share, up 6% from a year earlier, on net sales of $430 million (up 1%). For the first nine months, net income was flat at $140 million. Management updated 2025 guidance to $1.47 billion in sales (up 1%) and diluted EPS of $5.12 (flat versus 2024), citing slower-than-anticipated growth through September and softer demand in several international markets.
Q3 2025 net sales $430 million, up 1%; diluted EPS $2.05 vs. $1.93 a year earlier
Nine-month net sales $1.10 billion, up 1%; diluted EPS $4.36 vs. $4.34
Updated full-year 2025 guidance: $1.47 billion in sales and $5.12 diluted EPS; 2026 initial guidance due November 18, 2025
Quarterly dividend of $0.80 per share payable December 31, 2025, to holders of record December 15, 2025
Ingevity reported third-quarter 2025 results and revised its full-year 2025 guidance to total net sales of $1.25 billion to $1.35 billion and total adjusted EBITDA of $390 million to $405 million. The company said the revision reflects challenges in its Advanced Polymer Technologies segment, and it reported $43.5 million in net income, including discontinued operations, compared with a net loss of $107.2 million a year earlier.
Net sales from continuing operations were $333.1 million, flat compared with the prior year quarter.
Diluted EPS was $1.18 in the quarter, versus a diluted loss per share of $2.94 a year earlier; continuing operations diluted EPS was $1.10.
Full-year 2025 guidance: total net sales of $1.25 billion to $1.35 billion and total adjusted EBITDA of $390 million to $405 million.
The sale of most of the Industrial Specialties product line and the North Charleston crude tall oil refinery for $110 million is expected to close by early 2026.
MetLife reported third-quarter 2025 net income of $818 million, or $1.22 per share, down 36% from a year earlier, mainly due to higher net derivative losses and net investment losses. Adjusted earnings rose 15% to $1.6 billion, and adjusted earnings per share rose 22% to $2.37, driven by higher variable investment income and volume growth.
Net income was $818 million ($1.22 per share), down 36% from $1,275 million in the third quarter of 2024; net derivative losses were $929 million.
Adjusted earnings were $1,584 million, up 15%; adjusted earnings per share were $2.37, up 22%.
Premiums, fees and other revenues were $12.5 billion, flat compared with the prior-year quarter.
MetLife returned approximately $875 million to shareholders through share repurchases and common stock dividends, and held $4.9 billion in holding company cash and liquid assets at quarter end.
Enact Holdings reported third-quarter 2025 net income of $163 million, or $1.10 per diluted share, down from $181 million, or $1.15 per share, a year earlier, and slightly below the second quarter's $168 million. The company raised its expected total 2025 capital return to approximately $500 million and declared a $0.21 quarterly dividend, while the loss ratio rose to 15% from 5% a year ago.
Net income was $163 million, or $1.10 per diluted share, versus $181 million, or $1.15, in Q3 2024
Adjusted operating income was $166 million, or $1.12 per diluted share, versus $182 million, or $1.16, in Q3 2024
Loss ratio was 15%, compared with 5% in Q3 2024 and 10% in Q2 2025
Expected total 2025 capital return raised to approximately $500 million; $0.21 dividend payable December 11, 2025
Crane NXT reported third quarter 2025 net sales of $445.1 million, up 10.3% from a year earlier, with GAAP EPS of $0.87 versus $0.81 and Adjusted EPS of $1.28 versus $1.16. The company raised its full-year sales growth guidance to 9% to 11% but narrowed its Adjusted EPS guidance to $4.00 to $4.10, down from $4.00 to $4.30 at the top end, citing macroeconomic uncertainty affecting demand in its CPI segment.
Q3 net sales of $445.1 million rose 10.3%, including a $28.3 million benefit from the De La Rue Authentication Solutions acquisition; GAAP EPS was $0.87 versus $0.81.
Adjusted EPS was $1.28 versus $1.16 in the prior-year quarter.
Full-year 2025 sales growth guidance raised to +9% to +11% from +6% to +8%.
Adjusted EPS guidance narrowed to $4.00 to $4.10 from $4.00 to $4.30; quarterly dividend of $0.17 per share is payable December 10, 2025.
Genworth reported third-quarter 2025 net income available to common stockholders of $116 million, or $0.28 per diluted share, up from $51 million in the prior quarter and $85 million a year earlier. Adjusted operating income fell to $17 million, or $0.04 per diluted share, from $68 million in the prior quarter and $48 million a year earlier. The company also announced a new $350 million share repurchase authorization, and the GAAP result was helped by $78 million of net investment gains and a $34 million tax benefit.
Net income available to common stockholders was $116 million ($0.28 diluted), versus $51 million in Q2 2025 and $85 million in Q3 2024.
Adjusted operating income was $17 million ($0.04 diluted), versus $68 million in Q2 2025 and $48 million in Q3 2024.
Net income included a $34 million tax benefit and $78 million of net investment gains; Long-Term Care Insurance adjusted operating loss was $100 million.
Board authorized a new $350 million share repurchase program; $76 million was executed in the quarter.
Albemarle reported third-quarter 2025 net sales of $1.3 billion, down 3.5% from a year earlier, mainly on lower Energy Storage pricing. The company posted a net loss of $161 million, or $1.72 per diluted share, which includes a non-cash goodwill impairment charge tied to Ketjen, but adjusted EBITDA rose 7% to $226 million and management said full-year 2025 results are now expected toward the higher end of its $9/kg lithium price scenario ranges, which matters to shareholders because it signals a stronger expected year despite the charge.
Net sales were $1.3 billion, down 3.5% from $1.35 billion in the third quarter of 2024; Energy Storage pricing fell 16% while volumes rose 8%.
Net loss attributable to Albemarle was $161 million, or $1.72 per diluted share, including a $181 million goodwill impairment charge associated with Ketjen.
Adjusted EBITDA was $226 million, up 7%; adjusted loss was $0.19 per diluted share versus $1.55 a year earlier.
Full-year 2025 outlook was enhanced toward the higher end of the $9/kg scenario ranges, capital expenditures are now expected at about $600 million, and positive free cash flow of $300 million to $400 million is expected.
Global Net Lease reported third-quarter 2025 revenue of $121.0 million, down from $138.7 million a year earlier, mainly due to asset dispositions including the multi-tenant retail portfolio sale. It raised its full-year 2025 AFFO per share guidance to $0.95 to $0.97 from $0.92 to $0.96, and Fitch upgraded its corporate credit rating to investment-grade BBB-. For shareholders, lower revenue and AFFO per share were partly offset by a narrower net loss, the higher guidance range and a $2.0 billion reduction in net debt since third quarter 2024.
Q3 2025 revenue was $121.0 million versus $138.7 million in Q3 2024; AFFO was $53.2 million, or $0.24 per share, versus $73.9 million, or $0.32 per share
Net loss attributable to common stockholders narrowed to $71.1 million from $76.6 million a year earlier
Full-year 2025 AFFO per share guidance raised to $0.95 to $0.97 from $0.92 to $0.96; Net Debt to Adjusted EBITDA guidance unchanged at 6.5x to 7.1x
Fitch upgraded the corporate credit rating to investment-grade BBB- from BB+; company completed a $1.8 billion refinancing of its Revolving Credit Facility and repurchased 12.1 million shares for $91.7 million year-to-date through October 3
Devon Energy reported third-quarter 2025 net earnings of $687 million, or $1.09 per diluted share, down from $899 million in the second quarter and $812 million a year earlier, while total revenues rose to $4.3 billion. Production of 853,000 barrels of oil equivalent per day exceeded the top end of guidance, and the company gave fourth-quarter and 2026 production and capital outlooks, with 2026 capital projected at $3.5 billion to $3.7 billion.
Net earnings were $687 million, or $1.09 per diluted share; core earnings were $656 million, or $1.04 per diluted share.
Operating cash flow was $1.7 billion and free cash flow was $820 million.
Production averaged 853,000 Boe per day, above the top end of guidance; 2026 production is projected at 835,000 to 855,000 Boe per day.
The company declared a quarterly dividend of $0.24 per share, payable Dec. 30, 2025, and repurchased $250 million of shares in the quarter.
EnerSys reported fiscal second-quarter 2026 net sales of $951.3 million, up 7.7% from a year earlier and above its guidance range of $870 million to $910 million. GAAP diluted EPS fell to $1.80 from $2.01 because of $28.6 million in unfavorable highlighted items, while adjusted diluted EPS rose to $2.56 from $2.12. The company gave third-quarter guidance but kept full-year quantitative guidance paused, citing the macroeconomic environment.
Net sales of $951.3 million, up 7.7%, above the $870 million to $910 million guidance range
GAAP diluted EPS of $1.80 versus $2.01 a year earlier; adjusted diluted EPS of $2.56 versus guidance of $2.33 to $2.43
Third-quarter fiscal 2026 outlook: net sales of $920 million to $960 million and adjusted diluted EPS of $2.71 to $2.81; full-year quantitative guidance paused
Quarterly dividend of $0.2625 per share, payable December 26, 2025, to holders of record as of December 12, 2025
Universal Corporation reported results for the quarter ended September 30, 2025, with sales up 6% to $754.2 million and operating income down 2% to $67.6 million. The company also added Gregory A. Trojan, a retired restaurant, retail and consumer products executive, to its board, expanding it to 10 members effective November 5, 2025.
Q2 sales and other operating revenue $754.2 million vs. $710.8 million a year earlier, up 6%
Q2 operating income $67.6 million vs. $68.7 million, down 2%; non-GAAP adjusted operating income down 15% from $79.3 million
Q2 diluted EPS $1.36 vs. $1.03; non-GAAP adjusted diluted EPS $1.36 vs. $1.45, down 6%
Gregory A. Trojan appointed director effective November 5, 2025; expected to join the Audit, Compensation and Human Resources, and Finance and Pension Investment committees
e.l.f. Beauty reported second-quarter fiscal 2026 results for the three months ended September 30, 2025, with net sales up 14% to $343.9 million but GAAP net income down to $3.0 million from $19.0 million a year earlier. The company also issued fiscal 2026 guidance calling for net sales of $1,550 million to $1,570 million and adjusted diluted EPS of $2.80 to $2.85, compared with fiscal 2025 adjusted EPS of $3.39.
Q2 net sales rose 14% to $343.9 million; gross margin fell about 165 basis points to 69%, mainly due to higher tariff costs
GAAP diluted EPS was $0.05 versus $0.33 a year earlier; adjusted diluted EPS was $0.68 versus $0.77
Adjusted EBITDA was $66.2 million, down 4% year over year
Fiscal 2026 outlook: adjusted net income of $165 million to $168 million, versus $198 million in fiscal 2025
Third-quarter oil and gas sales rose to $1.32 billion from $1.22 billion a year earlier, but net income attributable to Class A shareholders fell to $59.2 million, or $0.08 per diluted share, from $386.4 million, or $0.53. The filing also shows a $264.3 million loss on extinguishment of debt, compared with $5.1 million a year earlier. The company raised its midpoint 2025 production guidance and said no other guidance ranges changed.
Oil and gas sales were $1.32 billion for the quarter ended September 30, 2025, versus $1.22 billion a year earlier.
Net income attributable to Class A Common Stock was $59.2 million ($0.08 diluted), versus $386.4 million ($0.53) in the third quarter of 2024.
Loss on extinguishment of debt was $264.3 million, versus $5.1 million a year earlier.
Midpoint 2025 guidance raised to 181.5 MBbls/d for oil and 394.0 MBoe/d for total production; fourth quarter base dividend declared at $0.15 per share, payable December 31, 2025.
CONMED reported third quarter 2025 sales of $337.9 million, up 6.7% year over year, while GAAP diluted EPS fell to $0.09 from $1.57 a year earlier, after product rationalization costs and other charges. The company also raised the midpoint of its adjusted EPS guidance, authorized a $150.0 million share repurchase program, and suspended its quarterly cash dividend, which matters to shareholders because it changes how cash is returned to them.
Q3 2025 sales were $337.9 million, up 6.7% as reported and 6.3% in constant currency.
GAAP diluted EPS was $0.09 versus $1.57 in Q3 2024; adjusted diluted EPS was $1.08 versus $1.05.
Full-year 2025 adjusted diluted EPS guidance is $4.48 to $4.53, compared with the prior $4.40 to $4.55.
Board authorized a $150.0 million buyback effective October 31, 2025 and suspended the quarterly dividend; at least $25.0 million in annual repurchases is expected from 2026.
CoreCivic reported third-quarter 2025 revenue of $580.4 million, up 18.1% from a year earlier, and net income of $26.3 million, or $0.24 per diluted share. It lowered its full-year 2025 guidance, citing start-up expenses at four newly contracted facilities that it expects to weigh on fourth-quarter results, while saying those facilities should support stronger 2026 results.
Q3 2025 net income was $26.3 million, or $0.24 per diluted share, compared with $21.1 million, or $0.19, in Q3 2024.
Full-year 2025 net income guidance was revised to $107.0 million to $113.0 million, down from $116.4 million to $124.4 million.
Full-year 2025 adjusted EBITDA guidance was revised to $355.0 million to $359.0 million, down from $365.0 million to $371.0 million.
In Q3 2025 the company repurchased 1.9 million shares for $40.0 million; $197.9 million of repurchase authorization remained as of September 30, 2025.
Vir Biotechnology reported third quarter 2025 results for the period ended September 30, 2025. Net loss narrowed to $163.1 million, or $1.17 per share, from $213.7 million, or $1.56 per share, a year earlier, mainly because license expenses were lower than in the prior-year quarter, but total revenues fell to $0.2 million from $2.4 million. The company said it had $810.7 million in cash, cash equivalents and investments and expects that to fund operations into mid-2027.
Net loss was $163.1 million, or $1.17 per share, versus $213.7 million, or $1.56 per share, in Q3 2024
Total revenues were $0.2 million versus $2.4 million in Q3 2024; R&D expenses were $151.5 million versus $195.2 million
Cash, cash equivalents and investments were $810.7 million at September 30, 2025, down about $81.4 million in the quarter; ECLIPSE 1 Phase 3 enrollment completed about two months early
TKO Group Holdings reported third-quarter 2025 revenue of $1.120 billion, down 27% from the prior year, mainly because the prior-year period included IMG revenue from the 2024 Paris Olympics. Net income rose to $106.8 million from $3.4 million, and Adjusted EBITDA increased 59% to $360.2 million, so profit and guidance improved while revenue declined. The company raised its full-year 2025 revenue and Adjusted EBITDA targets.
Q3 2025 revenue was $1.120 billion, down $420.8 million (27%) from the prior-year period, primarily due to IMG's prior-year Paris Olympics revenue.
Net income was $106.8 million versus $3.4 million a year earlier; Adjusted EBITDA was $360.2 million, up 59%.
Full-year 2025 revenue guidance was raised to $4.690 billion to $4.720 billion, and Adjusted EBITDA guidance to $1.570 billion to $1.580 billion.
Free cash flow was $398.9 million versus $151.0 million a year earlier; cash and equivalents were $861.4 million and gross debt was $3.759 billion as of September 30, 2025.
Fortinet reported third-quarter 2025 revenue of $1.72 billion, up 14% from a year earlier, and billings of $1.81 billion, also up 14%. GAAP net income fell to $473.9 million from $539.9 million, while non-GAAP diluted earnings per share rose to $0.74 from $0.63. The company expects fourth-quarter 2025 revenue of $1.825 billion to $1.885 billion and full-year 2025 revenue of $6.720 billion to $6.780 billion.
GAAP diluted EPS was $0.62 for the quarter, versus $0.70 a year earlier.
Non-GAAP diluted EPS was $0.74, versus $0.63; non-GAAP operating margin was 36.9%, versus 36.1%.
Product revenue grew 18% to $559.3 million; billings grew 14% to $1.81 billion.
Q4 2025 guidance: revenue of $1.825 billion to $1.885 billion and non-GAAP diluted EPS of $0.73 to $0.75.
Schrödinger reported third-quarter 2025 total revenue of $54.3 million, up 54% from a year earlier, and a net loss of $32.8 million, narrower than the $38.1 million loss in the prior-year quarter. The company lowered its full-year 2025 software revenue growth guidance to 8% to 13% from 10% to 15%, and said it expects savings of approximately $70 million from expense-reduction measures and a shift away from independent clinical development.
Q3 total revenue was $54.3 million, up 54%; software revenue was $40.9 million, up 28%, and drug discovery revenue was $13.5 million versus $3.4 million a year earlier.
Full-year 2025 software revenue growth guidance was cut to 8% to 13% from 10% to 15%, while drug discovery revenue guidance was raised to $49 million to $52 million from $45 million to $50 million.
Q3 net loss was $32.8 million, versus $38.1 million in Q3 2024; non-GAAP net loss was $42.3 million.
Cash, cash equivalents, restricted cash and marketable securities totaled $401.0 million at September 30, 2025.
Resideo reported third quarter 2025 net revenue of $1.86 billion, up 2% year over year, and net income of $156 million, compared with $20 million a year earlier. Diluted EPS was $0.85 versus $0.07, and Adjusted EPS was $0.89 versus $0.59. The company also paid Honeywell $1.59 billion in August 2025 to terminate the Indemnification Agreement, which left reported operating cash flow negative at $1.57 billion for the quarter, and it issued an updated full-year 2025 outlook.
Q3 2025 net revenue $1.86 billion, up 2%; Adjusted EBITDA $229 million, up 21% from $190 million
Diluted EPS $0.85 vs $0.07 in Q3 2024; Adjusted EPS $0.89 vs $0.59
Reported operating cash used was $1.57 billion, including the $1.59 billion Honeywell payment; adjusted cash provided by operations was $19 million
Updated 2025 outlook: net revenue $7.43 billion to $7.47 billion; Adjusted EBITDA $818 million to $832 million; Adjusted EPS $2.57 to $2.67
QuidelOrtho reported third-quarter 2025 results with revenue of $700 million, down 4% from $727 million a year earlier, mainly due to lower COVID-19 and Donor Screening revenue. A $701 million non-cash goodwill impairment charge drove a GAAP net loss of $733 million, while adjusted diluted EPS was $0.80 versus $0.85 and adjusted EBITDA rose to $177 million from $171 million. The company narrowed its full-year 2025 revenue and adjusted EBITDA guidance ranges and updated adjusted EPS guidance to $2.00 to $2.15 to reflect its debt refinancing.
Q3 2025 total revenue was $700 million, down 4% as reported; non-respiratory revenue rose 5% as reported
GAAP diluted loss per share was $10.78 versus a $0.30 loss a year earlier, including a $701 million goodwill impairment charge
Adjusted EBITDA was $177 million, a 25% margin, compared with $171 million and 23% a year earlier
Full-year 2025 guidance: revenue $2.68 to $2.74 billion, adjusted EBITDA $585 to $605 million, adjusted diluted EPS $2.00 to $2.15
Sabra Health Care REIT reported third-quarter 2025 total revenues of $190.0 million, up from $178.0 million a year earlier, while diluted net income fell to $0.09 per share from $0.13. The company updated its 2025 earnings guidance and reported normalized FFO of $0.36 per diluted share, up from $0.35, which shows the mixed picture for shareholders.
Total revenues were $190.0 million for the quarter ended September 30, 2025, versus $178.0 million a year earlier.
Diluted net income was $0.09 per share versus $0.13 a year earlier; normalized FFO was $0.36 per share versus $0.35.
2025 guidance was updated to net income of $0.655 to $0.665 per diluted share and normalized FFO of $1.455 to $1.465 per diluted share.
Board declared a quarterly dividend of $0.30 per share, payable November 28, 2025, to holders of record on November 17, 2025.
Grand Canyon Education reported third quarter 2025 service revenue of $261.1 million, up 9.6% from a year earlier, but diluted earnings per share fell to $0.58 from $1.42 after a $35.0 million reserve for the settlement of a qui tam lawsuit. The company also gave fourth quarter and full year 2025 outlook, including full year diluted EPS of $7.66 to $7.77 on a GAAP basis, which includes the litigation reserve.
Q3 service revenue rose 9.6% to $261.1 million; GCU online enrollments rose 9.6% to 107,815.
Q3 net income fell 60.8% to $16.3 million; diluted EPS was $0.58 versus $1.42. Adjusted diluted EPS was $1.78 versus $1.48.
Full year 2025 guidance: service revenue of $1,103.0 million to $1,108.0 million and diluted EPS of $7.66 to $7.77 (adjusted $9.02 to $9.13).
Unrestricted cash and investments were $277.0 million at September 30, 2025, down from $324.6 million at December 31, 2024.
Warrior Met Coal reported third quarter 2025 net income of $36.6 million, or $0.70 per diluted share, down from $41.8 million, or $0.80, a year earlier, while total revenues edged up to $328.6 million from $327.7 million. The company raised its full-year 2025 production and sales volume guidance by about 10% after starting longwall operations at its Blue Creek mine eight months ahead of schedule, and lowered its cash cost of sales guidance, though lower coal prices weighed on earnings.
Net income was $36.6 million, or $0.70 per diluted share, versus $41.8 million, or $0.80, in Q3 2024.
Total revenues were $328.6 million versus $327.7 million; sales volumes rose 27% to a record 2.4 million short tons while the average net selling price fell 21% to $135.87 per short ton.
2025 production guidance was raised to 9.4-9.8 million short tons and cash cost of sales guidance was lowered to $105-$110 per short ton.
Blue Creek longwall operations began in October, eight months ahead of schedule; the Board declared a $0.08 per share quarterly dividend payable November 14, 2025.
LegalZoom reported third-quarter 2025 revenue of $190.2 million, up 13% from a year earlier, and raised its full-year 2025 revenue outlook to $748 million to $752 million, about 10% growth at the midpoint. Net income fell to $4.5 million from $11.1 million and Adjusted EBITDA slipped to $46.3 million from $47.1 million, so profit measures weakened even as sales grew.
Q3 revenue was $190.2 million, up 13%; subscription revenue was $125.4 million, up 13%.
Q3 net income was $4.5 million versus $11.1 million a year earlier, down 59%; Adjusted EBITDA was $46.3 million versus $47.1 million.
Full-year 2025 revenue guidance was raised to $748 million to $752 million; Q4 revenue is expected at $182 million to $186 million.
Cash and cash equivalents were $237.2 million as of September 30, 2025; free cash flow was $47.0 million in the quarter.
PTC reported fourth-quarter fiscal 2025 revenue of $894 million, up 43% from a year earlier, and diluted EPS of $2.94 versus $1.04, both above its own Q4 guidance. For fiscal 2026 it guided to revenue of $2.65 billion to $2.915 billion and GAAP EPS of $4.37 to $6.87, versus $6.14 in fiscal 2025, with guidance including the pending divestiture of Kepware and ThingWorx.
Q4 2025 revenue $894 million, up 43% year over year; Q4 guidance was $725 million to $785 million
Q4 diluted EPS $2.94 versus $1.04; FY25 diluted EPS $6.14 versus $3.12
FY26 guidance: revenue $2.65 billion to $2.915 billion; GAAP EPS $4.37 to $6.87; guidance will be updated when the divestiture closes
Share repurchases to increase under the $2 billion authorization, with approximately $200 million expected in Q1 2026
STAAR Surgical reported third quarter 2025 results for the period ended September 26, 2025. Net sales rose 6.9% from a year earlier to $94.7 million, helped by $25.9 million from a December 2024 China shipment that was paid in full this quarter, while net income fell to $8.9 million, or $0.18 per diluted share, from $10.0 million, or $0.20 per share. Because the company is being acquired by Alcon Inc., it will not hold a conference call on the results.
Net sales were $94.7 million, up 6.9% from $88.6 million a year earlier, including $25.9 million from the December China Shipment.
Net sales excluding China were $38.9 million, up 7.7% year over year.
Net income was $8.9 million, or $0.18 per diluted share, versus $10.0 million, or $0.20 per share, a year earlier; the company recorded $5.9 million in merger transaction costs.
Adjusted EBITDA was $34.6 million, or $0.68 per share, compared with $16.2 million, or $0.33 per share, a year earlier.
AOS reported fiscal first-quarter 2026 revenue of $182.5 million, up 3.4% from the June quarter and flat from a year earlier, and a GAAP net loss of $2.1 million, down from $77.1 million in the June quarter. The company expects fiscal second-quarter revenue of approximately $160 million, plus or minus $10 million, which is below the current quarter. Shareholders face a narrower loss alongside a lower revenue outlook.
Revenue was $182.5 million, up 3.4% from the June 30, 2025 quarter and flat from the September 30, 2024 quarter.
GAAP net loss was $2.1 million, or $0.07 per diluted share, versus a $77.1 million loss ($2.58 per share) in the prior quarter.
Non-GAAP net income was $4.2 million, or $0.13 per diluted share, versus $0.21 a year earlier.
Fiscal Q2 revenue is expected to be approximately $160 million, plus or minus $10 million, for the quarter ending December 31, 2025.
Cytokinetics reported third quarter 2025 results on November 5, 2025, with revenue of $1.9 million, up from $0.5 million a year earlier. The net loss widened to $306.2 million, or $(2.55) per share, from $160.5 million, or $(1.36) per share, including a $121.2 million debt conversion expense tied to the exchange of $399.5 million of 2027 Notes. The company narrowed its full-year 2025 GAAP operating expense guidance to $680 million to $700 million from $670 million to $710 million, and said it is preparing for the December 26, 2025 FDA action date for aficamten.
Q3 2025 total revenues were $1.9 million, compared with $0.5 million in Q3 2024.
Q3 2025 net loss was $306.2 million, or $(2.55) per share, versus $160.5 million, or $(1.36) per share, a year earlier.
Full-year 2025 GAAP operating expense guidance is $680 million to $700 million, versus a prior range of $670 million to $710 million.
Cash, cash equivalents and investments were approximately $1.25 billion as of September 30, 2025.
Sempra reported third-quarter 2025 GAAP earnings of $77 million, or $0.12 per diluted share, down from $638 million, or $1.00, a year earlier. Adjusted earnings rose to $728 million, or $1.11 per share, from $566 million, or $0.89, and revenue rose to $3.151 billion from $2.776 billion. The GAAP decline reflects a $514 million tax charge tied to the planned sale of Sempra Infrastructure Partners, a transaction Sempra says will close in Q2 to Q3 2026.
Third-quarter revenue was $3.151 billion, up from $2.776 billion in the third quarter of 2024.
GAAP EPS was $0.12 versus $1.00 a year earlier; adjusted EPS was $1.11 versus $0.89.
The quarter included $514 million in net income tax expense tied to classifying SI Partners as held for sale.
Sempra updated its full-year 2025 GAAP EPS guidance to $3.05 to $3.45 and affirmed adjusted EPS guidance of $4.30 to $4.70 and 2026 EPS guidance of $4.80 to $5.30.
XPEL reported third-quarter 2025 revenue up 11.1% to $125.4 million, while net income fell 11.8% to $13.1 million, or $0.47 per share, as gross margin and operating expenses moved against profit. The company also said it plans to invest $75 million to $150 million over the next two years in manufacturing and supply chain, with a goal of lifting gross margin to 52% to 54% by the end of 2028.
Q3 2025 revenue was $125.4 million, up 11.1% from $112.9 million a year earlier; gross margin was 41.8%, down from 42.5%.
Q3 2025 net income was $13.1 million, or $0.47 per share, versus $14.9 million, or $0.54 per share, in Q3 2024.
Company expects fourth-quarter 2025 revenue of approximately $123 million to $125 million.
Planned investment of $75 million to $150 million over the next two years, targeting gross margin of 52% to 54% and operating margin in the mid to high 20% range by the end of 2028.
Choice Hotels reported third quarter 2025 results on November 5, 2025, with total revenues up 5% to $447.3 million and net income of $180.0 million, compared with $105.7 million a year earlier. Net income includes a $100 million gain from remeasuring the company's previously held 50% stake in Choice Hotels Canada, and adjusted diluted EPS fell to $2.10 from $2.23. The company raised its full-year net income guidance but lowered its adjusted diluted EPS and adjusted net income guidance.
Q3 total revenues rose 5% to $447.3 million; net income was $180.0 million, or $3.86 diluted EPS, versus $2.22 a year earlier.
Adjusted diluted EPS was $2.10 versus $2.23 in Q3 2024; excluding listed items, the company said it would have been $2.27, up 2%.
Full-year 2025 net income guidance was raised to $353-$371 million from $261-$276 million; adjusted diluted EPS guidance was lowered to $6.82-$7.05 from $6.88-$7.20.
U.S. RevPAR fell 3.2% in Q3 2025, while international RevPAR rose 9.5%; full-year U.S. RevPAR guidance is now -3% to -2%, versus -3% to 0% previously.
Power Integrations reported third-quarter 2025 revenue of $118.9 million, up 3% from the prior quarter and the year-earlier quarter, but swung to a GAAP net loss of $1.4 million, or $0.02 per diluted share, from net income of $0.25 per share a year earlier. The company forecast fourth-quarter revenue of $100 million to $105 million and raised its quarterly dividend to $0.215 per share for each quarter of 2026.
Q3 2025 revenue was $118.9 million, up 3% year over year; non-GAAP net income was $20.2 million, or $0.36 per diluted share, versus $0.40 a year earlier
GAAP net loss was $1.4 million, or $0.02 per diluted share, compared with net income of $0.25 per diluted share in Q3 2024; stock-based compensation was $21.2 million in the quarter
Q4 2025 revenue is expected to be $100 million to $105 million
Repurchased 919 thousand shares for $42.4 million in Q3, completing the repurchase authorization; quarterly dividend increased to $0.215 per share for 2026
ACM Research reported third-quarter 2025 revenue of $269.2 million, up 32.0% from a year earlier, and narrowed its 2025 revenue guidance to $875 million to $925 million from $850 million to $950 million. Profit measures were mixed: GAAP operating income fell to $28.9 million from $44.2 million, while GAAP diluted EPS rose to $0.52 from $0.45, helped by an $18.7 million unrealized investment gain, and non-GAAP diluted EPS fell to $0.36 from $0.63.
Q3 2025 revenue was $269.2 million, up 32.0% from $204.0 million; GAAP gross margin fell to 42.0% from 51.4%.
GAAP operating income was $28.9 million versus $44.2 million; GAAP diluted EPS was $0.52 versus $0.45.
2025 revenue guidance narrowed to $875 million to $925 million from $850 million to $950 million.
ACM Shanghai raised approximately $623 million in net proceeds in September 2025; ACM's ownership of ACM Shanghai fell to 74.6% from 81.1%.
Southwest Gas Holdings reported third-quarter 2025 results that include a large gain from completing the separation of Centuri, its former subsidiary. Net income attributable to the company was $270.5 million, compared with $0.3 million a year earlier, while income from continuing operations was $4.2 million and consolidated operating revenues fell to $316.9 million from $359.1 million. The company reaffirmed its 2025 Southwest Gas net income guidance of $265 million to $275 million, with net income expected toward the top end of that range.
Q3 2025 net income attributable to the company was $270.5 million, versus $0.3 million in Q3 2024, driven by a net gain on Centuri deconsolidation of about $278.8 million.
Income from continuing operations was $4.2 million, or $0.06 per diluted share, versus a loss of $9.2 million, or $(0.13) per share, a year earlier.
Consolidated operating revenues were $316.9 million for the quarter, down from $359.1 million in Q3 2024.
S&P upgraded the company and Southwest Gas to BBB+ on September 22, 2025; 2025 net income guidance of $265 million to $275 million was reaffirmed.
Sonos reported fourth-quarter and fiscal 2025 results for the period ended September 27, 2025. Q4 revenue rose 13% year over year to $287.9 million and Adjusted EBITDA was $6.4 million, compared with negative $22.6 million a year earlier, while full-year revenue fell to $1,443.3 million from $1,518.1 million and the GAAP net loss widened to $61.1 million. The company did not provide guidance in the release and said it will do so on its earnings call.
Q4 revenue of $287.9 million, up from $255.4 million in the prior-year quarter
Q4 GAAP net loss narrowed to $37.9 million from $53.1 million; Q4 non-GAAP net loss was $6.8 million
Fiscal 2025 revenue of $1,443.3 million, down from $1,518.1 million; non-GAAP diluted EPS of $0.64 versus $0.49
No forward guidance in the release; company will provide guidance on its November 5, 2025 earnings call
Radian reported third quarter 2025 results on November 4, 2025. Net income from continuing operations was $153 million, or $1.11 per diluted share, compared with $167 million, or $1.09 per share, a year earlier, while total revenues fell to $303 million from $313 million. Per-share earnings edged up, but total earnings and revenue declined year over year, and the company is also pursuing a $1.7 billion acquisition of Inigo, expected to close in the first quarter of 2026.
Net income from continuing operations was $153 million, or $1.11 per diluted share, versus $167 million, or $1.09, in Q3 2024.
Total revenues were $303 million, compared with $313 million in Q3 2024 and $299 million in Q2 2025.
Adjusted diluted net operating income per share was $1.15, compared with $1.10 in Q3 2024.
Book value per share was $34.34 at September 30, 2025, up 9% from $31.37 a year earlier; the Inigo acquisition for $1.7 billion is expected to close in Q1 2026.
Scotts Miracle-Gro reported fiscal 2025 results for the year ended September 30, 2025, with net sales down 4% to $3.41 billion from $3.55 billion. GAAP diluted EPS was $2.47, compared with a loss of $0.61 a year earlier, and adjusted EPS rose to $3.74 from $2.29. The company also gave fiscal 2026 guidance calling for adjusted EPS of $4.15 to $4.35, which matters to shareholders as a benchmark for next year's earnings.
Fiscal 2025 net sales were $3,413.1 million, down from $3,552.7 million; fourth-quarter net sales fell 7% to $387.4 million
GAAP diluted EPS was $2.47 for fiscal 2025 versus a loss of $0.61 in fiscal 2024; adjusted diluted EPS was $3.74 versus $2.29
Fourth-quarter net loss narrowed to $151.8 million from $244.0 million a year earlier
Fiscal 2026 guidance includes adjusted EPS of $4.15 to $4.35 and free cash flow of $275 million
Payoneer reported third quarter 2025 results on November 5, 2025, with revenue up 9% to $270.9 million, while net income fell 66% to $14.1 million. The company raised its 2025 revenue guidance to $1,050 million-$1,070 million and its adjusted EBITDA guidance to $270 million-$275 million. For shareholders, revenue growth and higher guidance are offset by lower net income and diluted earnings per share of $0.04, down from $0.11.
Revenue of $270.9 million in Q3 2025, up 9% from $248.3 million a year earlier; revenue excluding interest income rose 15%.
Net income of $14.1 million, down 66% from $41.6 million, with tax expense of $16.4 million compared with a tax benefit of $19.5 million a year earlier.
Adjusted EBITDA of $71.3 million, up 3% from $69.3 million.
2025 guidance: revenue of $1,050 million-$1,070 million and adjusted EBITDA of $270 million-$275 million.
Vishay Intertechnology reported fiscal third-quarter 2025 revenue of $790.6 million, up from $762.3 million in the prior quarter and $735.4 million a year earlier. The company posted a GAAP loss of $0.06 per share, which included a $13.7 million charge tied to changes in tax laws, while adjusted EPS was $0.04. Management expects fourth-quarter revenue of $790 million, plus or minus $20 million.
Net revenues of $790.6 million, compared with $762.3 million in the June 28, 2025 quarter and $735.4 million in the September 28, 2024 quarter.
GAAP loss per share of $(0.06), compared with earnings of $0.01 in the prior quarter and a loss of $(0.14) a year earlier; adjusted EPS was $0.04.
Gross margin of 19.5%, including a negative impact of about 150 basis points related to Newport, versus 20.5% a year earlier.
Fourth-quarter 2025 outlook: revenue of $790 million plus or minus $20 million and gross margin of 19.5% plus or minus 50 basis points.
Charles River reported third-quarter 2025 revenue of $1.00 billion, down 0.5% from $1.01 billion a year earlier, and non-GAAP diluted EPS of $2.43, down 6.2% from $2.59. GAAP diluted EPS was $1.10, down from $1.33, mainly due to a $0.33 per share loss on venture capital and strategic investments. The company narrowed its 2025 outlook to the middle and upper ends of its prior revenue and EPS ranges, with non-GAAP EPS now estimated at $10.10 to $10.30.
Q3 revenue was $1.00 billion, down 0.5%; organic revenue fell 1.6%.
Non-GAAP diluted EPS was $2.43, down 6.2% from $2.59; GAAP diluted EPS was $1.10 versus $1.33.
2025 non-GAAP EPS estimate is now $10.10 to $10.30, compared with $9.90 to $10.30 previously.
RMS segment revenue rose 7.9% to $213.5 million, while DSA revenue fell 2.3% to $600.7 million.
Steve Madden reported third quarter 2025 revenue up 6.9% to $667.9 million, but net income attributable to the company fell to $20.5 million, or $0.29 per diluted share, from $55.3 million, or $0.77, a year earlier. The company cited new tariffs on imported goods as the main drag and expects fourth quarter revenue to rise 27% to 30% with diluted EPS of $0.30 to $0.35.
Revenue rose 6.9% to $667.9 million; net income attributable to Steve Madden fell to $20.5 million, or $0.29 per diluted share, from $55.3 million, or $0.77
Wholesale revenue fell 10.7% to $442.7 million; direct-to-consumer revenue rose 76.6% to $221.5 million, including the Kurt Geiger acquisition
Fourth quarter 2025 outlook: revenue expected to increase 27% to 30%; diluted EPS expected between $0.30 and $0.35
Board declared a quarterly dividend of $0.21 per share, payable December 26, 2025, to holders of record as of December 15, 2025
Performance Food Group reported first-quarter fiscal 2026 results for the quarter ended September 27, 2025. Net sales rose 10.8% to $17.1 billion and Adjusted EBITDA rose 16.6% to $480.1 million, but net income fell 13.3% to $93.6 million and diluted EPS fell 13.0% to $0.60. The company raised its full-year fiscal 2026 net sales outlook, while keeping its Adjusted EBITDA outlook unchanged.
Net sales rose 10.8% to $17.1 billion, with the Cheney Brothers acquisition cited as a main driver.
Net income fell 13.3% to $93.6 million, and diluted EPS was $0.60 versus $0.69 a year earlier.
Full-year fiscal 2026 net sales outlook raised to $67.5 billion to $68.5 billion from $67 billion to $68 billion; Adjusted EBITDA outlook unchanged at $1.9 billion to $2.0 billion.
Free cash flow was negative $224.1 million, and $500 million remained available for share repurchases as of September 27, 2025.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.